UT Health Cancer Center

San Antonio, Texas 78260

1 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Intrahepatic, Gallbladder Adenocarcinoma, Pain, Pancreatic Cancer, Peripheral Neuropathies

Studies at this site

• MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles — Recruiting now
• Breast/Evaluation of Cryotherapy and TRPA1 Receptors in Chemotherapy Induced Neuropathy — Completed
• Women's Mammography Study to Improve Comfort During Mammography — Completed
• A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors — Stopped early
• Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy — Stopped early
• Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma — Stopped early